https://www.mychesco.com/a/news/regional/the-lancet-publishes-pivotal-phase-3-data-on-csls-first-in-class-garadacimab-for-hae/
The Lancet Publishes Pivotal Phase 3 Data on CSL's First-in-Class Garadacimab for HAE